Love the news, hate the timeline.
• The duration of paxalisib’s enrollment period in GBM AGILE is expected to total
approximately 30 – 36 months, plus follow-up, but will depend on emerging study
data, recruitment rates, and other variables
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia executes GBM Agile study agreement
Ann: Kazia executes GBM Agile study agreement, page-7
-
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online